Concord Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$1.05K	–	877
2025 Q2	$1.05K	Sell	2 -1,999	-100%	-$1.12M	﹤0.01%	753
2025 Q1	$1.27M	Buy	2,001 +739	+59%	+$508K	0.21%	103
2024 Q4	$899K	Buy	1,262 +273	+28%	+$229K	0.15%	108
2024 Q3	$1.04M	Buy	989 +89	+10%	+$99K	0.17%	96
2024 Q2	$946K	Buy	900 +370	+70%	+$359K	0.17%	104
2024 Q1	$510K	Buy	530 +49	+10%	+$46.6K	0.09%	137
2023 Q4	$422K	Buy	481 +421	+702%	+$347K	0.08%	141
2023 Q3	$49.4K	Sell	60 -291	-83%	-$229K	0.01%	380
2023 Q2	$252K	Buy	351 +145	+70%	+$112K	0.05%	174
2023 Q1	$169K	Buy	206 +33	+19%	+$24.9K	0.05%	187
2022 Q4	$125K	Buy	+173	New	+$128K	0.04%	218
2022 Q3	–	Sell	-241	Closed	-$142K	–	908
2022 Q2	$142K	Buy	241 +83	+53%	+$54K	0.04%	209
2022 Q1	$110K	Buy	158 +8	+5%	+$5.06K	0.03%	287
2021 Q4	$95K	Buy	150 +135	+900%	+$83K	0.02%	316
2021 Q3	$9K	Sell	15 -98	-87%	-$60.8K	﹤0.01%	486
2021 Q2	$63K	Buy	113 +12	+12%	+$6.08K	0.02%	314
2021 Q1	$48K	Buy	+101	New	+$49.2K	0.02%	347